N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3,3,3-trifluoropropanamide;3-cyclopropyl-1-[2-[(2-methyl-1,3-benzothiazol-6-yl)oxy]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]azetidin-3-ol;N-(5-methyl-1H-pyrazol-3-yl)-2-(2-methylquinolin-6-yl)sulfanyl-6-(3-pyrrolidin-1-ylazetidin-1-yl)pyrimidin-4-amine;molecular hydrogen
C70H85F4N21O3S4 — CID 158101254
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3,3,3-trifluoropropanamide;3-cyclopropyl-1-[2-[(2-methyl-1,3-benzothiazol-6-yl)oxy]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]azetidin-3-ol;N-(5-methyl-1H-pyrazol-3-yl)-2-(2-methylquinolin-6-yl)sulfanyl-6-(3-pyrrolidin-1-ylazetidin-1-yl)pyrimidin-4-amine;molecular hydrogen
N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3,3,3-trifluoropropanamide;3-cyclopropyl-1-[2-[(2-methyl-1,3-benzothiazol-6-yl)oxy]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]azetidin-3-ol;N-(5-methyl-1H-pyrazol-3-yl)-2-(2-methylquinolin-6-yl)sulfanyl-6-(3-pyrrolidin-1-ylazetidin-1-yl)pyrimidin-4-amine;molecular hydrogen (PubChem CID 158101254) has the molecular formula C70H85F4N21O3S4 and a molecular weight of 1472.85 g/mol. Its IUPAC name is N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3,3,3-trifluoropropanamide;3-cyclopropyl-1-[2-[(2-methyl-1,3-benzothiazol-6-yl)oxy]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]azetidin-3-ol;N-(5-methyl-1H-pyrazol-3-yl)-2-(2-methylquinolin-6-yl)sulfanyl-6-(3-pyrrolidin-1-ylazetidin-1-yl)pyrimidin-4-amine;molecular hydrogen.
Molecular Properties
| Compound Name | N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3,3,3-trifluoropropanamide;3-cyclopropyl-1-[2-[(2-methyl-1,3-benzothiazol-6-yl)oxy]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]azetidin-3-ol;N-(5-methyl-1H-pyrazol-3-yl)-2-(2-methylquinolin-6-yl)sulfanyl-6-(3-pyrrolidin-1-ylazetidin-1-yl)pyrimidin-4-amine;molecular hydrogen |
|---|---|
| PubChem CID | 158101254 |
| Molecular Formula | C70H85F4N21O3S4 |
| Molecular Weight | 1472.85 g/mol |
| Exact Mass | 1471.60 |
| IUPAC Name | N-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3,3,3-trifluoropropanamide;3-cyclopropyl-1-[2-[(2-methyl-1,3-benzothiazol-6-yl)oxy]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-4-yl]azetidin-3-ol;N-(5-methyl-1H-pyrazol-3-yl)-2-(2-methylquinolin-6-yl)sulfanyl-6-(3-pyrrolidin-1-ylazetidin-1-yl)pyrimidin-4-amine;molecular hydrogen |
| SMILES | Cc1cc(Nc2cc(N3CC(O)(C4CC4)C3)nc(Oc3ccc4nc(C)sc4c3)n2)n[nH]1.Cc1ccc2cc(Sc3nc(Nc4cc(C)[nH]n4)cc(N4CC(N5CCCC5)C4)n3)ccc2n1.Cc1cnc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(NC(=O)CC(F)(F)F)cc3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H] |
| InChI | InChI=1S/C25H28N8S.C23H22F4N6OS2.C22H23N7O2S.6H2/c1-16-5-6-18-12-20(7-8-21(18)26-16)34-25-28-22(27-23-11-17(2)30-31-23)13-24(29-25)33-14-19(15-33)32-9-3-4-10-32;1-13-10-28-20(35-13)30-17-8-18(33-11-22(24,12-33)14-2-3-14)32-21(31-17)36-16-6-4-15(5-7-16)29-19(34)9-23(25,26)27;1-12-7-19(28-27-12)24-18-9-20(29-10-22(30,11-29)14-3-4-14)26-21(25-18)31-15-5-6-16-17(8-15)32-13(2)23-16;;;;;;/h5-8,11-13,19H,3-4,9-10,14-15H2,1-2H3,(H2,27,28,29,30,31);4-8,10,14H,2-3,9,11-12H2,1H3,(H,29,34)(H,28,30,31,32);5-9,14,30H,3-4,10-11H2,1-2H3,(H2,24,25,26,27,28);6*1H |
| InChIKey | FPGZGXFHZQCDTG-UHFFFAOYSA-N |
| XLogP | 15.91 |
| TPSA | 280.98 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 102 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1472.85 |
| LogP ≤ 5 | 15.91 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 25 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158101254 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.